Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators

1 Institut fuer Pharmakologie und Toxikologie, Medizinische Fakultaet der RWTH Aachen, 52057 Aachen, Germany; 2 University of Chicago, Howard Hughes Medical Institute, Chicago, Illinois 60637; 3 St. Vincent's Hospital, Department of Medicine, Melbourne 3065; and 8 University of Queensland, Institute for Molecular Bioscience, St. Lucia, Queensland 4072, Australia; 4 University of Pennsylvania School of Medicine, Howard Hughes Medical Institute, Philadelphia, Pennsylvania 19104; 5 Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461; 6 Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina 27710; 7 Division of Chemical Biology, Molecular Pharmacology, Stanford University Medical Center, Stanford, California 94305; 9 Massachusetts Institute of Technology, Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142; Departments of 10 Obstetrics and Gynecology, 11 Surgery, and 12 Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110; 15 Department of Cellular and Molecular Medicine, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan; and 16 Institute of Pharmacology and Toxicology, CH1005 Lausanne, Switzerland The recent identification of several additional members of the family of sugar transport facilitators (gene symbol SLC2A, protein symbol GLUT) has created a heterogeneous and, in part, confusing nomenclature. Therefore, this letter provides a summary of the family members and suggests a systematic nomenclature for SLC2A and GLUT symbols. membrane transport; glucose transporters; glucose transporter genes